Literature DB >> 16141555

Neurotrophic effect of magnolol in the hippocampal CA1 region of senescence-accelerated mice (SAMP1).

Nobuaki Matsui1, Hiroshi Nakashima, Yuki Ushio, Toshimasa Tada, Akiko Shirono, Yoshiyasu Fukuyama, Kousuke Nakade, Haifeng Zhai, Yumiko Yasui, Nobuyuki Fukuishi, Reiko Akagi, Masaaki Akagi.   

Abstract

Magnolol has neurotrophic effects in primary cultured rat cortical neurons, which are expressed as the promotion of neurite outgrowth and neuronal survival. In this study, we investigated the protective effect of magnolol against age-related neuronal loss in the hippocampus using senescence-accelerated mouse (SAMP1). Magnolol (5, 10 mg/kg) was orally administered once a day for 14 d to 2- or 4-month-old mice, and evaluation was carried out when the mice were 4 or 6 months old. The density of neurofibrils decreased with aging in the stratum radiatum of the CA1 region in the hippocampus of SAMP1, not SAMR1. Treatment with magnolol significantly prevented the decrease of neurofibrils in the CA1, when it was administered in 2-month-olds. However, administration at 4 months of age did not result in a preventive effect. These findings suggest that the administration of magnolol before the initiation of neuronal loss may result in a protective effect in the hippocampus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16141555     DOI: 10.1248/bpb.28.1762

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  4 in total

1.  Neurotrophic effects of 7,8-dihydroxycoumarin in primary cultured rat cortical neurons.

Authors:  Li Yan; Xiaowen Zhou; Xing Zhou; Zheng Zhang; Huan-Min Luo
Journal:  Neurosci Bull       Date:  2012-05-18       Impact factor: 5.203

2.  Magnolol Protects against MPTP/MPP(+)-Induced Toxicity via Inhibition of Oxidative Stress in In Vivo and In Vitro Models of Parkinson's Disease.

Authors:  Akiko Muroyama; Aya Fujita; Cheng Lv; Shota Kobayashi; Yoshiyasu Fukuyama; Yasuhide Mitsumoto
Journal:  Parkinsons Dis       Date:  2012-05-08

3.  Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.

Authors:  Chi-Chang Weng; Zi-An Chen; Ko-Ting Chao; Ting-Wei Ee; Kun-Ju Lin; Ming-Huan Chan; Ing-Tsung Hsiao; Tzu-Chen Yen; Mei-Ping Kung; Ching-Han Hsu; Shiaw-Pyng Wey
Journal:  PLoS One       Date:  2017-03-03       Impact factor: 3.240

Review 4.  The search for, and chemistry and mechanism of, neurotrophic natural products.

Authors:  Yoshiyasu Fukuyama; Miwa Kubo; Kenichi Harada
Journal:  J Nat Med       Date:  2020-07-08       Impact factor: 2.343

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.